Market Overview:
The global nonaisoprenol market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for coenzyme Q10 and vitamin K2, which are produced using nonaisoprenols. North America is expected to lead the global nonaisoprenol market in terms of revenue during the forecast period, followed by Europe and Asia Pacific.
Product Definition:
A nonaisyoprenol is a type of terpenoid that is found in plants. It has a 9-carbon backbone and is used to produce other terpenes. Nonaisoprenol is important for the production of essential oils and other plant compounds.
90% Solanesol:
90% solanesol is a clear, colorless liquid with an odor similar to that of glycerin. It has a molecular weight of 132 and the structure is very similar to that of ethylene diamine (ED). 90% solanesol can be considered as one part of a class or family known as amines. The other members in this group are diethylenetriamine, triethylene tetraamine, etc.
95% Solanesol:
Nonaisoprenol, also known as 95% solanesol is a colorless liquid with an odor similar to petrol.
Application Insights:
Coenzyme Q10 was the leading application segment in terms of revenue generation in 2017. Coenzyme Q10 is an important enzyme that plays a vital role in energy metabolism and antioxidant defense system. The product finds application as a nutritional supplement for humans and animals to maintain good health.
The other applications include vitamin K2 and other products such as cosmetics, agrochemicals, pharmaceuticals, nutraceuticals among others. Vitamin K2 is expected to be the fastest-growing segment over the forecast period owing to increasing awareness about healthy lifestyle practices along with rising demand for dietary supplements across various regions including North America, Europe, Asia Pacific and Middle East & Africa among others.
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand from the pharmaceutical and cosmetic industries. The region is expected to maintain its dominance over the forecast period due to increasing consumer awareness regarding health, fitness, and wellness. Moreover, growing concerns over chronic diseases are projected to further boost product demand in North America.
Asia Pacific is anticipated to be one of the fastest-growing regional markets during the forecast years on account of rising population coupled with increasing per capita income levels in emerging economies such as China and India. These countries have a strong presence of vitamin K2 manufacturers who are looking at expanding their businesses by introducing new products based on nonsoppsol technology for producing Vitamin K2 rather than using synthetic methods that involve production of Q10 as an intermediate which has adverse effects on human health (Chen 2012). This factor will also contribute towards growth prospects for nonaisoprenol derived Vitamin K2 products in Asia Pacific region during 2018 - 2030 time frame.
Growth Factors:
- Increasing demand from end-use industries such as pharmaceuticals, agrochemicals, and flavors & fragrances
- Growing preference for natural products over synthetic products
- Rising awareness about the benefits of Nonaisoprenol among consumers
- Technological advancements in extraction and purification processes of Nonaisoprenol
- Expansion of distribution channels
Scope Of The Report
Report Attributes
Report Details
Report Title
Nonaisoprenol Market Research Report
By Type
90% Solanesol, 95% Solanesol
By Application
Coenzyme Q10, Vitamin K2, Other
By Companies
ExtRx, Zhejiang Yixin Pharmaceutical, Sanming Huajian Bioengineering, ExtRx
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Nonaisoprenol Market Report Segments:
The global Nonaisoprenol market is segmented on the basis of:
Types
90% Solanesol, 95% Solanesol
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coenzyme Q10, Vitamin K2, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ExtRx
- Zhejiang Yixin Pharmaceutical
- Sanming Huajian Bioengineering
- ExtRx
Highlights of The Nonaisoprenol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 90% Solanesol
- 95% Solanesol
- By Application:
- Coenzyme Q10
- Vitamin K2
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nonaisoprenol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nonaisoprenol is a type of medication used to treat high blood pressure. It works by relaxing the blood vessels and reducing the amount of blood that flows through them. This can help to lower your blood pressure.
Some of the key players operating in the nonaisoprenol market are ExtRx, Zhejiang Yixin Pharmaceutical, Sanming Huajian Bioengineering, ExtRx.
The nonaisoprenol market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nonaisoprenol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nonaisoprenol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nonaisoprenol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nonaisoprenol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nonaisoprenol Market Size & Forecast, 2020-2028
4.5.1 Nonaisoprenol Market Size and Y-o-Y Growth
4.5.2 Nonaisoprenol Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 90% Solanesol
5.2.2 95% Solanesol
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Coenzyme Q10
6.2.2 Vitamin K2
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nonaisoprenol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nonaisoprenol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 90% Solanesol
9.6.2 95% Solanesol
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Coenzyme Q10
9.10.2 Vitamin K2
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 90% Solanesol
10.6.2 95% Solanesol
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Coenzyme Q10
10.10.2 Vitamin K2
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 90% Solanesol
11.6.2 95% Solanesol
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Coenzyme Q10
11.10.2 Vitamin K2
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 90% Solanesol
12.6.2 95% Solanesol
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Coenzyme Q10
12.10.2 Vitamin K2
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 90% Solanesol
13.6.2 95% Solanesol
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Coenzyme Q10
13.10.2 Vitamin K2
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nonaisoprenol Market: Competitive Dashboard
14.2 Global Nonaisoprenol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ExtRx
14.3.2 Zhejiang Yixin Pharmaceutical
14.3.3 Sanming Huajian Bioengineering
14.3.4 ExtRx
